NRXP - NRx Pharmaceuticals, Inc.

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Currency in USD
Earnings estimateCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
No. of analysts3333
Avg. Estimate-0.14-0.13-0.56-0.38
Low estimate-0.15-0.15-0.6-0.53
High estimate-0.13-0.11-0.51-0.19
Year ago EPS-0.11-0.14-0.61-0.56
Revenue estimateCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
No. of analysts3333
Avg. EstimateN/AN/AN/A2.23M
Low estimateN/AN/AN/AN/A
High estimateN/AN/AN/A6.7M
Year ago salesN/AN/AN/AN/A
Sales growth (year/est)N/AN/AN/AN/A
Earnings history29/06/202229/09/202230/12/202230/03/2023
Est. EPS-0.1-0.14-0.14-0.14
Actual EPS-0.11-0.14-0.16-0.16
Difference-0.010-0.02-0.02
Surprise %-10.00%0.00%-14.30%-14.30%
EPS trendCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
Current estimate-0.14-0.13-0.56-0.38
7 days ago-0.13-0.12-0.53-0.36
30 days ago-0.13-0.12-0.5-0.35
60 days ago-0.13-0.12-0.55-0.18
90 days ago-0.14-0.14-0.59-0.29
EPS revisionsCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
Up last 7 daysN/AN/A1N/A
Up last 30 daysN/AN/A1N/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/A11
Growth estimatesNRXPIndustrySector(s)S&P 500
Current qtr.-27.30%N/AN/AN/A
Next qtr.7.10%N/AN/AN/A
Current year8.20%N/AN/AN/A
Next year32.10%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A